V. Local Operational Setup & Implementation Steps
5.1 Legal Entity Establishment & Capital Allocation
The strategy requires the establishment of dual legal entities to achieve functional isolation and risk optimization:
Regional Holding & IP Entity (Singapore)
| Item | Content |
|---|---|
| Entity Type | Private Limited (Pte. Ltd.) |
| Strategic Function | Regional HQ, IP Holding, Treasury Management, Advanced Compliance |
| Core Value | Secures core technology assets and manages regional data under strict privacy regulations. |
Operational & Localization Entity (Indonesia)
| Item | Content |
|---|---|
| Entity Type | Foreign Investment Limited Liability Company (PT PMA) |
| Min. Investment | 10 Billion IDR (Approx. 1M SGD) |
| Paid-up Capital | 2.5 Billion IDR (Approx. 250k SGD) |
| Strategic Function | TKDN Target Achievement, Local Sales, Clinical Collaboration |
Capital Planning
The minimum investment must be planned before Phase II begins, as it is a mandatory requirement by the Indonesian government.
5.2 Organizational Structure: Elite Centralization & Local Execution
The organizational structure should reflect the Hub-and-Spoke model:
┌─────────────────────────────────┐
│ Singapore HQ (Hub) │
│ High-cost, High-pro AI R&D & Reg │
└────────────┬────────────────────┘
│
┌─────────────────────┼─────────────────────┐
│ │ │
▼ ▼ ▼
┌────────────────┐ ┌────────────────┐ ┌────────────────┐
│ Indonesia │ │ Thailand │ │ Other ASEAN │
│ MR/Clinical Adp│ │ Comm. Launch │ │ Regional Exp. │
└────────────────┘ └────────────────┘ └────────────────┘5.2.1 Singapore HQ Core Team
| Position | Responsibilities |
|---|---|
| Regional Managing Director | Strategy, Finance, and High-level Gov/Partner relations |
| Chief Regulatory & Compliance Officer (CRCO) | HSA GL7 compliance, PDPA management, coordinating regional SaMD registration |
| Senior AI/ML R&D Lead | Core algorithm iteration and maintenance, ensuring continuous learning and validation |
Salary Note
The salary levels for Senior AI/ML R&D Leads reflect the premium cost of specialized talent in Singapore (avg S$153,200+).
5.2.2 Indonesia Localization Execution Team
| Position | Responsibilities | Importance |
|---|---|---|
| Country Manager | Local sales, public sector relations (JKN), TKDN strategy execution | Core Execution |
| Clinical Partnership Manager | Establish "Co-creation" relationships with local hospitals and academic institutions; drive PoC and local data validation | ⭐ Critical |
| Application Engineer / FAE | Digital Cloud Film installation, integration, field support for primary care AI tools | Delivery Support |
5.3 Strategic Partnership Ecosystem
In Southeast Asia, partnerships are not just distribution channels but a means of mitigating regulatory and operational risks.
5.3.1 Regional Distribution & Channel Partners
| Partner Type | Role | Example |
|---|---|---|
| Regional Distributor | Handles logistics, imports, and local sales channels | MEDs Technologies (ASEAN coverage) |
| ICR Service Provider | Meets mandatory In-Country Representative requirements in markets like Thailand | Local Compliance Agent |
5.3.2 Clinical & Academic Partners
Priority Target
Prioritize collaboration with National Medical Centers for joint clinical research.
| Partner Type | Value | Example |
|---|---|---|
| Top-tier Specialist Hospitals | Access to local real-world data; accelerate AI model adaptation | Dharmais Cancer Center (Indonesia) |
| Academic Institutions | Proof of local R&D contribution for TKDN | Local University Medical Schools |
Partnership Value:
- Access to local real-world data.
- Accelerate AI model adaptation.
- Serves as a key component of TKDN requirements.
- Demonstrates Jianpei's contribution to local R&D.
5.4 Case Study: Wuzhen Intelligent Hospital Model
::: important Replicable Benchmark Wuzhen Intelligent Hospital is China's first healthcare service complex fully adopting next-generation AI. Its operating model is directly replicable in overseas markets like Sabah, Malaysia. :::
5.4.1 Project Positioning & Results
| Item | Content |
|---|---|
| Launched | June 2024 |
| Core Positioning | National demonstration window for solving the "Last Mile" medical resource gap |
| Tech Framework | Integrated application of AI, IoT, Big Data, and 5G |
| Visitors | 20,000+ |
| Affiliated Clinics | 50+ |
5.4.2 "1+N" Operational Architecture
┌─────────────────────────────────┐
│ Wuzhen Hospital (Central Hub) │
│ Diagnosis, Rehab, Health Center │
└────────────┬────────────────────┘
│
┌──────────────────┼──────────────────┐
│ │ │
▼ ▼ ▼
┌────────────────┐ ┌────────────────┐ ┌────────────────┐
│ Smart Clinic 1 │ │ Smart Clinic 2 │ │ Affiliated N │
│ Triage, Screen │ │ Family Med │ │ Elder Care │
└────────────────┘ └────────────────┘ └────────────────┘5.4.3 Core Capability Output
| Layer | Content |
|---|---|
| AI Empowerment | "Dr. Wood" Cloud Imaging, AI-CDSS Doctor Assistant |
| Three Integrations | Patient Data, Medical Resources, Management Collaboration |
| Patient Services | Precision health education, surveys, medication/follow-up reminders, auto-registration |
Applicability in Sabah, Malaysia
Sabah is geographically dispersed with limited primary care resources. The Wuzhen "1+N" model (Central Hospital + Multiple Smart Clinics) is perfectly suited to solve the "Last Mile" problem there.
Change History
| Version | Date | Description | Author |
|---|---|---|---|
| 1.0 | 2025-12-16 | Initial Version | Gemini |
| 1.1 | 2025-12-16 | Added Wuzhen Intelligent Hospital case study (Section 5.4); explained applicability in Sabah. | Gemini |